Cancer Clinical Trials in Northeast Philadelphia | Cancer Research
Popular Terms and Pages:

Clinical Cancer Trials

We're always looking for better ways to prevent, diagnose, and treat cancer. Our participation in clinical trials furthers our knowledge and gives you the opportunity to contribute to the advancement of cancer care, while receiving the latest treatment options from clinical experts.

Why Participate in a Clinical Trial?

People participate in clinical trials with hope for:

  • A new, effective treatment
  • Extending life
  • Relieving pain or other symptoms
  • Contributing to advances that will help others

If you are eligible for a clinical trial, the choice to participate is always yours. We encourage you to discuss participation with your family members and physician.

Advancing Cancer Care through Clinical Trials

Clinical research — research studies with people — is essential before making a new cancer treatment widely available to the general public.

Our Institutional Review Board of highly qualified physicians, pharmacists, and others thoroughly reviews each clinical trial, applying the strictest quality standards to protect the well-being of our volunteer participants.

Past clinical trials have taught us much of what we know about cancer and its treatment. Volunteers in current clinical trials are paving the way for tomorrow’s cancer prevention, diagnosis, and treatments. We are grateful to the many people who have contributed to our enhanced knowledge.

Access to National Trials

We offer you access to national clinical trials with promising new treatments.

We have access to:

  • Trials sponsored by the National Cancer Institute
  • Select trials supported by the National Institutes of Health

Is a Clinical Trial Right for You?

Each trial has its own guidelines for eligibility. Speak to your doctor or contact Redeemer Health to find out if we offer a trial that is right for you. Call us at (215) 544-5832.

Holy Redeemer Hospital Clinical Trials

Breast

A221505: Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer.

A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients Who Have Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy. NCT#01901094

A191901: Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions. An Additional Support Program via Text Messaging and Telephone-based Counseling for Breast Cancer Patients receiving Hormonal Therapy. NCT#04379570 

NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer. Testing the drug atezolizumab or placebo with usual therapy in first-line HER2-positive metastatic breast cancer. NCT#03199885

RT Outcomes: Radiation Therapy Outcomes for Breast Cancer: A Clinical Trial gathering Prospective Data on Side Effects and Treatment Efficacy.

Genetic

EAY131: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial).

Other Studies

Lung Cancer Screening Program Using Low Dose CT Scan with Prospective Patient Outcome Data Collection: The National Cancer Institute (NCI) conducted a large national lung screening trial (NLST), which showed a benefit in detecting lung cancer earlier in heavy smokers using LDCT. Essentially, it comes down to how long and how much you have smoked in your lifetime. Currently, this screening test is covered by most insurances. When you call to make an appointment we will work with you to determine your specific coverage.

NCCAPS: NCI COVID-19 in Cancer Patients Study – A Longitudinal Natural History Study

For more information, call 215-938-LUNG or read about our Lung Cancer Screening Program.

For more information on Clinical Trials, please visit the following websites: